Morgan Stanley Agenus Inc Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Oct 17, 2024	BUY	$0.53 - $0.93 $1.39 Million - $2.44 Million	2,627,410 New	2,627,410 $1.52 Million
Q1 2024 Aug 16, 2024	BUY	$0.53 - $0.93 $20,517 - $36,003	38,713 Added 1.5%	2,627,410 $1.52 Million
Q1 2024 May 15, 2024	BUY	$0.53 - $0.93 $20,517 - $36,003	38,713 Added 1.5%	2,627,410 $1.52 Million
Q4 2023 Aug 16, 2024	BUY	$0.63 - $1.14 $1.63 Million - $2.95 Million	2,588,697 New	2,588,697 $2.15 Million
Q4 2023 Feb 13, 2024	BUY	$0.63 - $1.14 $364,977 - $660,435	579,329 Added 28.83%	2,588,697 $2.15 Million
Q3 2023 Nov 15, 2023	BUY	$1.12 - $1.88 $97,574 - $163,785	87,120 Added 4.53%	2,009,368 $2.27 Million
Q2 2023 Aug 14, 2023	BUY	$1.31 - $2.04 $480,437 - $748,161	366,746 Added 23.58%	1,922,248 $3.08 Million
Q1 2023 May 15, 2023	BUY	$1.45 - $2.95 $1.05 Million - $2.15 Million	727,338 Added 87.83%	1,555,502 $2.36 Million
Q4 2022 Feb 14, 2023	SELL	$2.02 - $3.25 $895,209 - $1.44 Million	-443,173 Reduced 34.86%	828,164 $1.99 Million
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.14 $2.26 Million - $3.62 Million	-1,152,334 Reduced 47.54%	1,271,337 $2.61 Million
Q2 2022 Oct 27, 2022	BUY	$1.3 - $2.64 $1.16 Million - $2.35 Million	891,340 Added 58.17%	2,423,671 $4.7 Million
Q2 2022 Aug 15, 2022	BUY	$1.3 - $2.64 $1.16 Million - $2.35 Million	891,340 Added 58.17%	2,423,671 $4.7 Million
Q1 2022 Oct 27, 2022	SELL	$2.35 - $3.47 $2.09 Million - $3.09 Million	-891,340 Reduced 36.78%	1,532,331 $3.77 Million
Q1 2022 May 13, 2022	SELL	$2.35 - $3.47 $229,658 - $339,112	-97,727 Reduced 6.0%	1,532,331 $3.77 Million
Q4 2021 Feb 14, 2022	BUY	$2.92 - $5.74 $1.27 Million - $2.5 Million	435,542 Added 36.46%	1,630,058 $5.25 Million
Q3 2021 Nov 15, 2021	BUY	$4.98 - $6.63 $5.95 Million - $7.92 Million	1,194,516 New	1,194,516 $6.27 Million

Others Institutions Holding AGEN

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account